Andrew Shooshtari, BS

Articles by Andrew Shooshtari, BS

Cancer Care Spending and Use by Site of Provider-Administered Chemotherapy in Medicare

ByAndrew Shooshtari, BS,Yamini Kalidindi, MHA,Jeah Jung, PhD

June 14th 2019

Differences in cancer care spending and utilization between Medicare beneficiaries receiving chemotherapy in hospital outpatient departments versus physician offices vary by service type.

Latest Updated Articles

Cancer Care Spending and Use by Site of Provider-Administered Chemotherapy in Medicare
June 14th 2019

Andrew Shooshtari, BS

Articles by Andrew Shooshtari, BS

Cancer Care Spending and Use by Site of Provider-Administered Chemotherapy in Medicare

Latest Updated Articles

Trending on AJMC

First-Line Vitiligo Treatment: Topical JAK Inhibitors and Phototherapy

Unanswered Questions in First- and Second-Line mCRC Care

Multidisciplinary Care for Vitiligo: Beyond Dermatology

Planning for Third-Line Therapy and Treatment Rechallenge in mCRC

Precision Drugs Meet Payer Realities

Delivering Cellular Therapy in Community Oncology: OHC’s Approach

Andrew Shooshtari, BS

Articles by Andrew Shooshtari, BS

Cancer Care Spending and Use by Site of Provider-Administered Chemotherapy in Medicare

Latest Updated Articles

Trending on AJMC

First-Line Vitiligo Treatment: Topical JAK Inhibitors and Phototherapy

Unanswered Questions in First- and Second-Line mCRC Care

Multidisciplinary Care for Vitiligo: Beyond Dermatology

Planning for Third-Line Therapy and Treatment Rechallenge in mCRC

Precision Drugs Meet Payer Realities